A recent norovirus outbreak aboard Royal Caribbean’s Serenade of the Seas cruise ship has affected over 100 passengers and a crew member during a 13-day voyage from San Diego to Miami, once again spotlighting the global and local health threats posed by this highly contagious virus. This incident recalls India’s 2025 outbreak of Guillain-Barré Syndrome […]
In India, breast cancer is no longer a distant threat—it affects thousands of lives every year, cutting across age, region, and economic divides. This October, as the nation observes Breast Cancer Awareness Month 2025, the powerful message by WHO resonates louder than ever: “Every Story is Unique, Every Journey Matters.” This is not just about
Every Story is Unique: Breast Cancer Awareness Month 2025 in India Read More »
President Donald Trump recently signed an executive order allocating $50 million in federal grants to advance artificial intelligence (AI) research focused on childhood cancer. This initiative expands the National Cancer Institute’s Childhood Cancer Data Initiative (CCDI), initially launched in 2019 with a $500 million budget over 10 years. The funding aims to harness AI technologies
In a major breakthrough for neurotechnology and patient care, UCLA researchers have unveiled a revolutionary non-invasive brain-computer interface (BCI) powered by artificial intelligence (AI). This wearable system dramatically improves the ability of both paralyzed and able-bodied individuals to control devices with their thoughts—without the need for risky brain surgery. The innovation is challenging the invasive
UCLA’s Non-Invasive AI BCI Advances Patient Care, Challenges Neuralink’s Approach Read More »
The NHS has reiterated advice to limit over‑the‑counter omeprazole to two weeks and to seek professional review if symptoms persist or worsen, a reminder that resonates across India where PPIs are among the most commonly used medicines and often continued without scheduled reassessment. What are Proton pump inhibitors Proton pump inhibitors like omeprazole work by
NHS warning on omeprazole: caution on 14‑day self‑use revives stewardship push for India Read More »
Walmart, the global retail giant, has recently removed certain ready-to-eat pasta meals from its stores across the United States after federal health officials discovered a potential contamination with Listeria monocytogenes—a dangerous bacterium that can cause serious foodborne illness. This recall follows a deadly listeria outbreak linked to similar products, raising concerns worldwide, including India where
A clear takeaway: Beyond the Tylenol–autism debate, JD Vance’s simple advice—“follow your doctor”—is the quiet shift that may keep policy practical and prevent panic in India’s paracetamol market. What was widely reported Indian coverage highlighted President Trump’s claim linking Tylenol (paracetamol) use in pregnancy to autism and amplified strong pushback from clinicians and scientists who
Travel expert Rick Steves recently shared the update of his prostate cancer diagnosis, bringing national attention to the critical importance of early detection for one of the most common cancers affecting American men. Steves’ open discussion about his condition, treatments, and outlook highlights the urgent need for more accessible and accurate detection methods. With this
A one-time gene therapy called AMT-130, developed by uniQure has, for the first time, shown a strong slowing of Huntington’s disease in people, with a reported 75% reduction in decline over three years in a small early-stage study, offering new hope to Indian families living with this inherited brain disorder. Experts call it a breakthrough
India’s first real hope as gene therapy slows Huntington’s Disease by 75% in early trial Read More »
In a major advance for colorectal cancer care, the ALASCCA trial, a large Nordic randomized, placebo-controlled, double-blind study involving 626 patients with surgically treated early-stage colorectal cancer, has shown that daily low-dose aspirin (160 mg) for three years can cut the risk of cancer recurrence in half, but only for patients with specific genetic mutations
